Mohammed Eslam

176 Hawkesbury Road
Westmead, NSW 2145, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 223 publications

Resmetirom and semaglutide therapy for patients with MAFLD in the MENA region: expert panel recommendations.

Resmetirom and semaglutide therapy for patients with MAFLD in the MENA region: expert panel recommendations.

Journal: Expert review of endocrinology & metabolism

Published: July 03, 2026

Cancer risk, metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated fatty liver disease: perspectives and methodological issues.

Cancer risk, metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated fatty liver disease: perspectives and methodological issues.

Journal: Internal medicine journal

Published: June 06, 2026

Liver disease care amid wars and conflicts.

Liver disease care amid wars and conflicts.

Journal: Nature reviews. Gastroenterology & hepatology

Published: May 01, 2026

Nationwide Trends of Noninvasive Tests for Liver Fibrosis in Japan Between 2014 and 2023.

Nationwide Trends of Noninvasive Tests for Liver Fibrosis in Japan Between 2014 and 2023.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: April 18, 2026

Assessment of MAFLD/MASLD Classification Using the Updated Lancet Obesity Definition.

Assessment of MAFLD/MASLD Classification Using the Updated Lancet Obesity Definition.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: April 16, 2026

The coexistence of MAFLD increases fibrosis burden in patients with chronic hepatitis B.

The coexistence of MAFLD increases fibrosis burden in patients with chronic hepatitis B.

Journal: Scientific reports

Published: April 04, 2026

Health inequity and the risk of MAFLD/MASLD.

Health inequity and the risk of MAFLD/MASLD.

Journal: Clinical nutrition ESPEN

Published: March 23, 2026

The AMAGE guidelines: Metabolic dysfunction-associated fatty liver disease through a regional lens.

The AMAGE guidelines: Metabolic dysfunction-associated fatty liver disease through a regional lens.

Journal: Annals of hepatology

Published: March 10, 2026

Hepatitis C elimination: is it time to redefine the goals?

Hepatitis C elimination: is it time to redefine the goals?

Journal: Nature reviews. Gastroenterology & hepatology

Published: February 23, 2026

Redefining Obesity Improves the Identification of Advanced Fibrosis Among MAFLD/MASLD Patients.

Redefining Obesity Improves the Identification of Advanced Fibrosis Among MAFLD/MASLD Patients.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: January 31, 2026

Reply to correspondence on "Hypothyroidism and the risk of liver-related events in patients with metabolic dysfunction-associated steatotic liver disease".

Reply to correspondence on "Hypothyroidism and the risk of liver-related events in patients with metabolic dysfunction-associated steatotic liver disease".

Journal: Clinical and molecular hepatology

Published: January 27, 2026

Metabolic liver disease research in the Arab world: a bibliometric analysis of trends, collaborations, and disparities (2006-2024).

Metabolic liver disease research in the Arab world: a bibliometric analysis of trends, collaborations, and disparities (2006-2024).

Journal: Minerva gastroenterology

Published: January 20, 2026

Showing 1-12 of 223

Last Updated: 09/26/2026